19 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
33
Selective Degradation of TEADs by a PROTAC Molecule Exhibited Robust Anticancer Efficacy In Vitro and In Vivo.

Shanghai Institute of Materia Medica
62
Modulators for palmitoylation of proteins and small molecules.

Hebei University
6
Novel Indazole Compounds as TEAD Inhibitors for Treating Cancer.

Smith, Gambrell & Russell
6
Novel Compounds as TEAD Inhibitors for Treating Cancer.

Smith, Gambrell & Russell
37
A chemical perspective on the modulation of TEAD transcriptional activities: Recent progress, challenges, and opportunities.

Shanghai Institute of Materia Medica
8
Small-Molecule Cyanamide Pan-TEAD·YAP1 Covalent Antagonists.

Indiana University
4
Diversity-oriented synthesis as a tool to expand the chemical space of DNA-encoded libraries.

University of Florence
23
Discovery of a selective and covalent small-molecule inhibitor of BFL-1 protein that induces robust apoptosis in cancer cells.

Yancheng Teachers University
2
Optimization of TEAD P-Site Binding Fragment Hit into In Vivo Active Lead

Merck Healthcare
4
Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors.

Lille Neuroscience and Cognition Research Center
37
Discovery of Covalent Inhibitors Targeting the Transcriptional Enhanced Associate Domain Central Pocket.

Max Planck Institute of Molecular Physiology
13
Structure-based design of potent linear peptide inhibitors of the YAP-TEAD protein-protein interaction derived from the YAP omega-loop sequence.

Novartis Institutes For Biomedical Research
2
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.

University of Bristol
3
Discovery and biological evaluation of vinylsulfonamide derivatives as highly potent, covalent TEAD autopalmitoylation inhibitors.

Shanghai Institute of Materia Medica
6
Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics.

Zhengzhou University
3
Targeting Transcriptional Enhanced Associate Domains (TEADs).

Universities of Lille
154
COMPOUND ACTIVE AS INHIBITOR OF COLONY STIMULATION FACTOR-1 RECEPTOR (CSF-1 R)

Norwegian University of Science and Technology
317
PYRAZOLYL DERIVATIVES AS INHIBITORS OF THE KRAS MUTANT PROTEIN

Novartis
9
UNIT DOSAGE COMPOSITION OF AKT INHIBITOR

Nanjing Chia Tai Tianqing Pharmaceutical